Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0004 Transporter Info
Gene Name ABCG2
Transporter Name Breast cancer resistance protein
Gene ID
9429
UniProt ID
Q9UNQ0
Microbiota Influence of This DT (MBI)

Bacteria: Pseudomonadota

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human ABCG2 substrates/drugs in the health condition [1]

Detailed Description

 The Escherichia coli str. K-12 substr. MG1655 has been reported to sequester the drug Ciprofloxacin and Tetracycline, which limits the distribution of the drug in the body and its binding to the drug transporter ABCG2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

 Inhibition of ABCG2 function in chronic kidney disease condition [2] , [3]

Regulating Factor
p-Cresol sulfate

Studied Phenotype

 Chronic kidney disease [ICD11: GB61]

Studied Tissue

 Kidney

In Vitro Model

 Human renal proximal tubule cells

Detailed Description

 The metabolite p-cresol sulfate generated from the metabolism of p-cresol by the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCG2.

       Microbe Influence 2

 Down regulating of ABCG2 expression in colon cancer condition [4]

Regulating Factor
Chenodeoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (T84)

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCG2.

       Microbe Influence 3

 Up regulating of ABCG2 expression in colon cancer condition [4]

Regulating Factor
Deoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCG2.

       Microbe Influence 4

 Up regulating of ABCG2 expression in hyperuricaemia condition [5]

Studied Phenotype

 Hyperuricaemia [ICD11: 5C55.Y]

Studied Tissue

 Kidney

In Vivo Model

 ICR specific-pathogen-free mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCG2.

       Microbe Influence 5

 Up regulating of ABCG2 expression in conventional mice compared with germ-free mice [6]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6N mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCG2.
References
1 Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 2017 May 18;545(7654):299-304.
2 Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins (Basel). 2018 Jul 19;10(7):300.
3 Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology. Toxicol In Vitro. 2015 Oct;29(7):1868-77.
4 Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein. Mol Pharm. 2018 Dec 3;15(12):5711-5727.
5 The gut microbiota mediates the protective effects of anserine supplementation on hyperuricaemia and associated renal inflammation. Food Funct. 2021 Oct 4;12(19):9030-9042.
6 Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice. Mol Pharm. 2016 Aug 1;13(8):2691-701.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.